Conagra Brands, Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -25

Conagra Brands stock rises 1.21 percent after earnings beat expectations

Earnings report Financial outlook AI-generated analysis

πŸ“ˆ Conagra Brands stock rose 1.21 percent to $13.36 after Q1 fiscal 2027 adjusted EPS of $0.41 beat the $0.28 consensus.

πŸ“‰ Organic net sales fell 1.1 percent as a 2.1 percent volume decline outweighed price and mix benefits.

πŸ’° Gross margins declined 50 basis points to 23.8 percent, signaling ongoing profitability challenges.

πŸ’Έ Operating cash flow turned negative at $4.2 million in Q1 FY2027 compared to $120.6 million a year prior.

🏦 Free cash flow was negative $127.9 million while net debt reached $7.4 billion with 3.99x leverage.

🎯 Management reaffirmed fiscal 2027 guidance for adjusted EPS of $1.40-$1.50 and organic sales growth of -3% to -1%.

πŸ“Š Analyst consensus is neutral with an average 12-month price target of $14.32, just 7.19% above current levels.

Bullish Signals
  • Conagra Brands beat Q1 fiscal 2027 adjusted EPS expectations, delivering $0.41 versus the $0.28 consensus.
  • Adjusted net income increased 4.3 percent to $197 million year-over-year despite lower sales volume.
Risk Factors
  • Organic net sales declined 1.1 percent as a 2.1 percent volume drop outweighed price and mix benefits.
  • Gross margins contracted by 50 basis points to 23.8 percent, indicating deteriorating profitability.
  • Operating cash flow turned negative at $4.2 million in Q1 FY2027 compared to $120.6 million the prior year.
  • Free cash flow was negative $127.9 million while net debt stood at $7.4 billion with 3.99x leverage.
Full Analysis
Conagra Brands reported first-quarter fiscal 2027 results that beat adjusted earnings per share (EPS) expectations, with the stock rising 1.21 percent to close at $13.36. The company delivered adjusted EPS of $0.41, surpassing the consensus estimate of $0.28, while reaffirming its full-year fiscal 2027 guidance for adjusted EPS between $1.40 and $1.50. Despite the earnings beat, underlying fundamentals showed mixed signals as organic net sales declined by 1.1 percent due to a volume drop of 2.1 percent that outweighed price and mix benefits. Gross margins contracted by 50 basis points to 23.8 percent, indicating ongoing pressure on profitability despite management's assertion that margin repair is progressing. Cash flow dynamics presented significant headwinds, with operating cash flow turning negative at $4.2 million compared to $120.6 million in the prior-year quarter, and free cash flow falling to a negative $127.9 million. The company's net debt stood at $7.4 billion with a leverage ratio of 3.99 times, highlighting financial strain as it relies on productivity gains to offset negative volume trends. Analyst sentiment remains cautious, with Investing.com listing a neutral consensus from 17 analysts and an average 12-month price target of $14.32, which sits just 7.19 percent above the current stock price. The market appears skeptical about the turnaround story given the persistent demand constraints and the gap between reported earnings quality and operational performance metrics.